In recent clinical trials of CFTR correctors and potentiators, decreased sweat chloride concentrations and increased CFTR function via NPD measurement have been correlated with improvement in the lung function and (body mass index) BMI of CF subjects. Here, CFTR is linked to cystic fibrosis.